<?xml version="1.0"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="Optica Fall Vision Meeting Abstract">
	<front>
		<journal-meta>
			<journal-id journal-id-type="hwp">jov</journal-id>
			<journal-id journal-id-type="publisher-id">JOVI</journal-id>
			<journal-title-group>
				<journal-title>Journal of Vision</journal-title>
			</journal-title-group>
			<issn pub-type="epub">1534-7362</issn>
			<publisher>
				<publisher-name>Association for Research in Vision and Ophthalmology</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="doi">10.1167/jov.23.13.78</article-id>
			<article-id pub-id-type="manuscript">Talks_78</article-id>
			<article-categories>
				<subj-group subj-group-type="category">
					<subject>Poster Session II</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Poster Session II: Non-degenerating double cone opsin knockout mouse model of blue cone monochromacy</article-title>
			</title-group>
			<contrib-group>
                          
				<contrib contrib-type="author">
					<name>
						<surname>Puska</surname>
						<given-names>Mikayla L.</given-names>
					</name>
                                        
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>


				</contrib>



				<contrib contrib-type="author">
					<name>
						<surname>Giarmarco</surname>
						<given-names>Michelle M.</given-names>
					</name>
                                        
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>


				</contrib>



				<contrib contrib-type="author">
					<name>
						<surname>Neitz</surname>
						<given-names>Jay</given-names>
					</name>
                                        
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>


				</contrib>



				<contrib contrib-type="author">
					<name>
						<surname>Neitz</surname>
						<given-names>Maureen</given-names>
					</name>
                                        
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>


				</contrib>



				<contrib contrib-type="author">
					<name>
						<surname>Kuchenbecker</surname>
						<given-names>James A.</given-names>
					</name>
                                        
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>


				</contrib>




                          
				<aff id="aff1">
					<label><sup>1</sup></label>
					<institution>Department of Ophthalmology, University of Washington</institution>
				</aff>


			</contrib-group>
			<pub-date pub-type="ppub"><month>11</month>
				<year>2023</year>
			</pub-date>
			<pub-date pub-type="epub"><month>11</month>
				<year>2023</year>
			</pub-date>
						<volume>23</volume>
						<issue>13</issue>
						<fpage>78</fpage>
						<lpage>78</lpage>
			<permissions>
				<license license-type="cc-by-nc-nd" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
					<license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.</license-p>
				</license>
			</permissions>
			<abstract>
				<p>Ma et al. (2022) performed opsin gene therapy in a mouse model of blue cone monochromacy (BCM). Treatment was only effective for young animals because the retina degenerated, with a significant reduction in the number viable cones by 3 months. Their mouse was created by mating an Opn1mw knockout with a gene trap inserted in intron 2 of the Opn1mw gene, to an Opn1sw knockout with the neomycin resistance gene inserted in intron 3 of the Opn1sw gene. The Opn1mw knockout was reported as having “greatly reduced” M opsin expression, while the Opn1sw knockout was a severely hypomorphic allele. Their double opsin gene knockout (DKO) mouse is not a good model of BCM, which is typically a stationary disorder with no cone degeneration. We evaluated Opn1mw Opn1sw DKO mice for cone degeneration; these mice were created by Regeneron by deleting both genes using genome editing. Eyes of 1 year old DKO animals were processed for cryosections. Sections were immunostained using antibodies against a variety of cone proteins (S and M opsins, arrestin) and markers for retinal degeneration, then confocal imaged. Despite the absence of both cone opsins, cones remain viable and morphologically normal, and the retina shows no signs of degeneration at 1 year. This DKO mouse model will be a valuable tool for developing gene therapies targeting cone opsins, and also for understanding color vision circuitry in the retina.</p>
			</abstract>
		</article-meta>
	</front>
	<back>
                
               <fn-group>
			<fn>
				<p>Funding: Funding: UW Vision Core Grant NIH NEI P30-EY001730, Research to Prevent Blindness</p>
			</fn>
		</fn-group>

	</back>
</article>